Navigation Links
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
Date:3/9/2010

"Morbidities and organ loss due to CMV have become a significant medical issue as the frequency of organ transplantation has increased and new immunosuppressive regimes have been introduced," said George Painter, Ph.D., President and Chief Executive Officer.  "CMX001 has demonstrated broad-spectrum activity in preclinical tests against double-stranded DNA viruses - including CMV - and has been well-tolerated to date among volunteers and patients.  We believe that with this combination of potent antiviral activity and tolerability, CMX001 will prove to be a powerful new treatment option for the transplant population and their physicians."

The Phase 2 clinical study is being conducted at approximately 25 leading academic and medical research centers in the United States.  Enrollment in the study is under way and will include approximately 120 patients.  Study participants will receive CMX001 once weekly following stem cell engraftment through post-transplant week 13, and will be monitored for CMV disease and viremia.  Participants will also be monitored for other dsDNA viruses susceptible to CMX001, including adenovirus, BK virus, and Epstein Barr virus.  Safety assessments will be conducted throughout the study.  

About CMX001


'/>"/>
SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
2. Chimerix to Present at Two Upcoming Investor Conferences
3. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
4. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
5. ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
6. Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer
7. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
8. Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
9. Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui
10. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
11. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014  A Boston Scientific Corporation (NYSE: ... stent removability and preliminary long term stricture resolution ... the August issue of the peer-reviewed journal, Gastroenterology. ... is being conducted in 11 countries and five ... metal stents (FCSEMS) after extended indwell (i.e., up ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "China Orthopedic Instrument Industry Report, 2014-2017" report to ... population and rising proportion of reimbursement for medical expenses, ... released, with its scale presenting a CAGR of 19.2% ... are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... 2014 Research and Markets has ... Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018" ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... China,s pharmaceutical equipment industry in the ... landscape, and business performance of domestic major enterprises, as ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4China Orthopedic Instrument Industry Report, 2014-2017 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... CB1,antagonist rimonabant to show benefits beyond weight reduction ... | March 08, 2007 | The Business Intelligence,firm ... antagonist Acomplia (rimonabant) has at least,five competitors in ... more,in earlier phases of R&D. While Acomplia received ...
... March, 9, 2007-Active Biotech (ACTI.ST), today,announced new positive clinical ... treatment of prostate cancer. , By step-wise dose escalation, ... which corresponds to a doubling of the previously,reported maximum ... a step-wise intra-patient dose-escalation enables a dose,of 1 mg/day ...
Cached Medicine Technology:Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 2Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 3Positive Clinical Data for TASQ - Active Biotech's Novel Treatment,of Prostate Cancer 2
(Date:8/30/2014)... MA (PRWEB) August 31, 2014 In a ... eat dog’ approach, Karma Web Group, LLC launches a game ... and Android the newly launched Ultimate Karma app is a ... with new levels of play, the game pulls double-duty by ... the same time. , Designed to reward gamers for consistently ...
(Date:8/30/2014)... August 31, 2014 This Labor Day, ... growing union in New York State and nationwide, is ... jobs and the best quality of care to New ... recent years, thousands of healthcare workers in the region ... families by becoming members of the healthcare workers’ union. ...
(Date:8/30/2014)... Atlanta based automotive group Jim Ellis Automotive ... and awareness for ALS by participating in the popular ... even Vice President Jimmy Ellis all participated in the ... viewed on their Youtube page; https://www.youtube.com/watch?v=pxufyxVo9j0 . , ... and staff also took the opportunity to challenge various ...
(Date:8/30/2014)... distinguished wedding dress supplier, has gained a great market response ... the company has unveiled its beautiful collection of “ flowy ... these brand new products are provided with big discounts, up ... unveil the new and trendy bridesmaid outfits and launch the ... low prices now. The purpose of our company is to ...
(Date:8/30/2014)... The Truth about Six Pack Abs is a ... users some shocking foods that can burn belly fat, unique ... as well as some motivation secrets for successful fitness. , ... one unique trick that can help users reduce junk-food cravings. ... people might think, cardio exercise routines are not the best ...
Breaking Medicine News(10 mins):Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 2Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 3Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 4Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2Health News:UWDress.com’s Beautiful Collection Of “Flowy Bridesmaid Dresses” Released 2Health News:Truth about Six Pack Abs Review Reveals Unique Method to Eliminate Stubborn Stomach Fat 2
... chronic myelogenous leukemia works for patients who have developed ... than other medications in its class, a research team ... D. Anderson Cancer Center reports at the 49th annual ... has shown good efficacy and very little toxicity compared ...
... Inc., a,developer of innovative technologies and products ... provider of QuantiGene(R) and,QuantiGene Plex(R) products for ... they have been awarded Frost & Sullivan,s ... of the Year,Award. Frost & Sullivan, a ...
... Dec. 11, 2007 Researchers at UT Southwestern Medical ... of Cushing syndrome, a metabolic disorder caused by adrenal ... The study, appearing in the December issue of the ... surgical outcomes reported in patients with subclinical Cushing syndrome ...
... 10 California,s,Fair Political Practices Commission today agreed ... cell board member John Reed, the,Foundation for Taxpayer ... non-profit consumer advocacy organization filed the,complaint two weeks ... the Burnham,Institute for Medical Research, because he improperly ...
... patients are suffering unnecessarily because they wrongly believe that morphine ... dying and as a last resort rather than seeing them ... life. , In a study published online today (Tuesday 11 ... in palliative care also say the belief that opioids hasten ...
... Dec. 10 Novo Nordisk Inc.,today announced the company ... Exubera(R) infringed patents owned by Novo Nordisk.,The patents cover ... originally filed in August 2006 in United States,Federal Court ... Nordisk is a healthcare company with an 84-year history ...
Cached Medicine News:Health News:Early Phase II results show bosutinib safe, effective for CML 2Health News:Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award 2Health News:Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award 3Health News:UT Southwestern: Patients with mild Cushing syndrome may benefit from adrenalectomy 2Health News:UT Southwestern: Patients with mild Cushing syndrome may benefit from adrenalectomy 3Health News:Fair Political Practices Commission Will Investigate Stem Cell Conflict of Interest 2Health News:Morphine: a comfort measure for the dying or pain control for the living? 2Health News:Morphine: a comfort measure for the dying or pain control for the living? 3Health News:Morphine: a comfort measure for the dying or pain control for the living? 4
... The Leica M520 OH3 ... the best optical performance available ... innovative and unique stand. The ... lightest, has the greatest range ...
Advanced operating microscope with high-resolution apochromatic optics. Senso-servo drive to keep the microscope in perfect balance even if parts are moved or mounted elsewhere....
PS Medical lumboperitoneal catheter systems are designed to divert CSF from the lumbar subarachnoid space to the peritoneal cavity, using simplified surgical techniques....
Curved left, Hardy Curettes, bayonet, working distance 120 mm, total length 241 mm....
Medicine Products: